SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine

JAMA Netw Open. 2021 Aug 2;4(8):e2119741. doi: 10.1001/jamanetworkopen.2021.19741.

Abstract

This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral / immunology*
  • Antibody Formation*
  • BNT162 Vaccine
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / administration & dosage*
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2 / immunology*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • BNT162 Vaccine